Literature DB >> 9202418

The apoptotic cysteine protease CPP32.

S Kumar1.   

Abstract

CPP32 (also called Yama and apopain) is a member of a growing family of cysteine proteases which includes the interleukin-1 beta-converting enzyme (ICE) and the product of the Caenorhabditis elegans cell death gene ced-3. CPP32 has been consistently implicated as a key protease of the ICE/CED-3 family that is activated in response to a variety of death stimuli. Active CPP32 consists of P17 and p12 subunits derived from a 32 kDa pro-enzyme. This activation can be mediated by some ICE-like proteases and the cytotoxic T-cell (CTL) protease granzyme B. Once activated, CPP32 can process some of the other ICE family members and cleaves several cellular proteins in apoptotic cells. Inhibitors of CPP32 and other ICE-like proteases are potent inhibitors of apoptosis and promise to be important therapeutic molecules for the treatment of diseases, such as neurodegenerative and autoimmune disorders, that arise from excessive ell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202418     DOI: 10.1016/s1357-2725(96)00146-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  16 in total

1.  Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway.

Authors:  Z Zhou; X Sun; Y J Kang
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review.

Authors:  Hao Chen; Xia Yang; Zhenbo Feng; Ruixue Tang; Fanghui Ren; Kanglai Wei; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury.

Authors:  G M Kim; J Xu; J Xu; S K Song; P Yan; G Ku; X M Xu; C Y Hsu
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

4.  Cellular stress in xenopus kidney cells enhances the phosphorylation of eukaryotic translation initiation factor (eIF)4E and the association of eIF4F with poly(A)-binding protein.

Authors:  C S Fraser; V M Pain; S J Morley
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

5.  Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma.

Authors:  Dechen Chodon; S Mumtaz Banu; R Padmavathi; D Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2006-09-28       Impact factor: 3.396

6.  G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.

Authors:  Venugopalan Cheriyath; Keith B Glaser; Jeffrey F Waring; Rachid Baz; Mohamad A Hussein; Ernest C Borden
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 7.  Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.

Authors:  Cheng-Jeng Tai; Chung-Huei Hsu; Shing-Chuan Shen; Woan-Ruoh Lee; Ming-Chung Jiang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-11

8.  Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections.

Authors:  Maryla Krajewska; Layton H Smith; Juan Rong; Xianshu Huang; Marc L Hyer; Nikolajs Zeps; Barry Iacopetta; Steven P Linke; Allen H Olson; John C Reed; Stan Krajewski
Journal:  J Histochem Cytochem       Date:  2009-03-16       Impact factor: 2.479

9.  Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway.

Authors:  Enrica Favaro; Ilaria Miceli; Benedetta Bussolati; Michel Schmitt-Ney; Michel Schimitt-Ney; Paolo Cavallo Perin; Giovanni Camussi; Maria M Zanone
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

10.  Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation.

Authors:  L Virág; G S Scott; S Cuzzocrea; D Marmer; A L Salzman; C Szabó
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.